Status:
COMPLETED
Heliox in Experimental Upper Airway Obstruction
Lead Sponsor:
University of Witten/Herdecke
Conditions:
Airway Obstruction
Dyspnea
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
Currently it is common medical wisdom that HELIOX (mixture of Helium in Oxygen) with a fraction of Helium below 60% is not effective in reducing airway obstruction. The investigators test the hypothes...
Detailed Description
HELIOX is a mixture of Helium and Oxygen. It is a therapeutic modality that can improve upper and lower airway obstruction. The lower density of Helium can help to relieve airway obstruction and is kn...
Eligibility Criteria
Inclusion
- Volunteers of both sexes were recruited via posting in student forum of University of Witten/Herdecke
- Willingness to spend about 2h in the clinical exp. lab.
Exclusion
- Acute airway infection
- History of asthma
- Smokers
- Pregnancy
- Abnormal lab. screen with liver function tests, Creat./BUN, CBC, blood glucose
- Anxiety or mood disorder
- Any chronic disease (incl. lung \& heart disease, cancer, endocrine disorder)
- Mental retardation
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00788788
Start Date
November 1 2007
Last Update
November 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HELIOS-Klinikum / University of Witten/Herdecke
Wuppertal, North Rhine-Westphalia, Germany, 42283